News

Wednesday, September 26th, 2018

Think Inside the Box! CONTINUUS to address drug shortages

Think Inside the Box! CONTINUUS was featured on a front cover page of pharmacy practice news regarding how ICM can effectively eliminate drug shortages.…
Thursday, September 21st, 2017

CONTINUUS awarded SBIR Phase IIB grant from the National Science Foundation

CONTINUUS Pharmaceuticals was awarded a Phase IIB SBIR grant from the National Science Foundation to accelerate technical development and commercialization of its ICM technology platform. The grant consists of $500,000 over a two year extension period, which increases the total…
Tuesday, June 13th, 2017

CONTINUUS Team meets FDA

The CONTINUUS Team has met with key FDA representatives for a progress update on the implementation of our end-to-end Integrated Continuous Manufacturing (ICM) process.  The picture below includes (from the left) Sap Chattopadhyay, Stephen Born, Salvatore Mascia, Bayan Takizawa, Vida…
Friday, March 24th, 2017

Mindset Change Needed to Drive Continuous Manufacturing Adoption – CONTINUUS at conference on continuous manufacturing

CONTINUUS was featured on PharmTech, including an interview with our Chief Business Officer Bayan Takizawa.…
Wednesday, February 1st, 2017

CONTINUUS Pharmaceuticals Awarded Best Italian Start-up

On January 9th, 2017 CONTINUUS CEO, Salvatore Mascia, was awarded a price for the 2017 Best Italian Start-Up abroad founded by an Italian entrepreneur.  The picture shows Salvatore receiving the award by the Italian Minister of Foreign Affairs, Angelino Alfano.…
Thursday, January 26th, 2017

CONTINUUS Pharmaceuticals enjoys successful 2016, looking forward to 2017

2016 marked a very successful year for CONTINUUS Pharmaceuticals.  The team was able to advance its innovative technology platform through work done with the National Science Foundation, as well as projects with commercial partners.  As a result, CONTINUUS was able…
Wednesday, December 28th, 2016

The Benefits of Continuous Manufacturing

CONTINUUS was featured on R&D Magazine in an exclusive Q&A with CONTINUUS Pharmaceuticals on continuous manufacturing operational best practices and trends for 2017.…
Wednesday, November 16th, 2016

CONTINUUS Pharmaceuticals Awarded $4.4 M Contract with US FDA

CONTINUUS Pharmaceuticals, Inc. was recently awarded a $4.4 M contract by the US Food and Drug Administration (US FDA).  The purpose of this collaborative work, entitled “Advancement of Integrated Continuous Manufacturing (ICM) Unit Operations,” is to develop a science and…
Tuesday, November 1st, 2016

CONTINUUS Pharmaceuticals Included in C&EN’s 10 Startups to Watch

Chemical & Engineering News included CONTINUUS Pharmaceuticals in its list of “10 Startups to Watch”. To learn more, please see:  http://cen.acs.org/articles/94/i43/Continuus-Pharmaceuticals.html…
Thursday, March 31st, 2016

Breakfast Meeting with Italian Prime Minister, Matteo Renzi

Salvatore Mascia met Italian Prime Minister, Matteo Renzi at a breakfast meeting in Boston, together with 14 other young Italian entrepreneurs. During his speech to the Prime Minister, Dr. Mascia introduced CONTINUUS’s ICM technology and mentioned the ongoing collaboration with…
Wednesday, March 23rd, 2016

CONTINUUS CEO Presents to the FDA on Integrated Continuous Manufacturing

Salvatore Mascia was invited by the FDA to give a presentation on CONTINUUS’s Integrated Continuous Manufacturing Platform. Dr. Mascia discussed all of the novel continuous manufacturing technologies under development at CONTINUUS, including an end-to-end process control system (based on Delta…
Tuesday, March 1st, 2016

CONTINUUS awarded SBIR Phase II grant from the National Science Foundation

CONTINUUS Pharmaceuticals was awarded a Phase II SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase II grant consists of $750,000 over a two year period, with the opportunity for additional matching funds…
Tuesday, November 3rd, 2015

CONTINUUS secures an additional contract for a top-selling generic medication

CONTINUUS Pharmaceuticals expanded its pipeline by securing a contract with a major pharmaceutical client. CONTINUUS will implement its innovative ICM technology platform for a top-selling generic pharmaceutical.  “This represents a great opportunity for generic pharmaceutical companies. Implementing ICM will allow…
Tuesday, July 21st, 2015

Interview with CONTINUUS CEO on PDA Letter

Salvatore Mascia, CEO, CONTINUUS Pharmaceuticals will present his talk on continuous manufacturing at the PDA Manufacturing Science Workshop in Washington, D.C., on September 30th 2015. Mascia spoke with the PDA Letter about his upcoming talk, and the interview was published…
Tuesday, June 16th, 2015

CONTINUUS Pharmaceuticals Presents at 2015 Annual BIO International Convention

CONTINUUS Pharmaceuticals presented its technology platform and product offerings at the 2015 BIO International Convention in Philadelphia on June 16.  CONTINUUS was one of only twelve companies selected by the National Science Foundation to be featured in the Company Presentations…
Monday, May 4th, 2015

MIT-Novartis spinout CONTINUUS Pharmaceuticals lands in Woburn

CONTINUUS was featured in the Boston Business Journal, click here to learn more.…
Thursday, April 23rd, 2015

CONTINUUS to present at the NSF/NIH Bio Innovation Zone during the 2015 BIO International Convention, June 15-18

CONTINUUS Pharmaceuticals was selected to present its technology at the 2015 BIO International Convention in Philadelphia during June 15-18.  CONTINUUS will showcase its work at the NSF/NIH Bio Innovation Zone, which has been funded by a Phase I SBIR grant…
Wednesday, April 15th, 2015

CONTINUUS Pharmaceuticals featured in World Pharmaceutical Frontiers

In the most recent edition of World Pharmaceutical Frontiers, CONTINUUS founder and CEO Salvatore Mascia was featured in an article discussing the future of the pharmaceutical manufacturing industry.  In this article, Salvatore puts forth the case for integrated continuous manufacturing…
Friday, April 10th, 2015

CONTINUUS Pharmaceuticals celebrates opening of new facility in Woburn, MA

CONTINUUS Pharmaceuticals hosted a ribbon-cutting ceremony to celebrate its new facility in Woburn, MA on April 10, 2015.  A number of industry and government representatives were in attendance, including CONTINUUS’s strategic partners:  I.M.A. Industria Macchine Automatiche, an Italian-based company, global…
Monday, January 12th, 2015

CONTINUUS awarded SBIR Phase I grant from the National Science Foundation

CONTINUUS Pharmaceuticals was awarded a Phase I SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase I grant consists of $150,000 over a six month period.…
Tuesday, December 16th, 2014

ICM Featured on Pharmaceutical Manufacturing and Pharmaceutical Technology Magazines

ICM was featured on the December 2014 Issue of Pharmaceutical Manufacturing. Click here to read the full article outlining the future of the pharmaceutical manufacturing industry. In addition, CONTINUUS Pharmaceutic was also featured on Pharmaceutical Technology Magazine among the latest…
Thursday, November 6th, 2014

CONTINUUS Partners with New England Controls to Implement Breakthrough Continuous Manufacturing Technology for Pharmaceuticals

Mansfield, MA (November 6, 2014): New England Controls announced a new partnership agreement with CONTINUUS Pharmaceuticals, a revolutionary spin-out company from the Massachusetts Institute of Technology (MIT). This agreement will create a path for CONTINUUS to bring their Integrated Continuous…
Monday, October 27th, 2014

Timothy F. Jamison to join CONTINUUS Advisory Board

CONTINUUS Pharmaceuticals is proud to announce that Timothy F. Jamison, Professor of Chemistry at MIT, will join its Board of Advisors. Prof. Jamison is a world renowned expert in continuous flow chemistry and is involved as a principal investigator at…
Tuesday, October 7th, 2014

CONTINUUS presents at Global Pharma Manufacturing Summit, IFPAC 2014, and Annual Northeast L.E.A.N. Conference

CONTINUUS Pharmaceuticals delivered a talk during the Innovation Spotlight Session at the Global Pharma Manufacturing Summit 2014 in Boston.  CONTINUUS also participated in a Continuous Manufacturing Session at IFPAC 2014 in Cortona, with many other industry leaders in continuous manufacturing,…
Monday, June 9th, 2014

CONTINUUS closes $2 M Series A Financing and establishes a strategic partnership with I.M.A. Industria Macchine Automatiche

On June 9, 2014, CONTINUUS Pharmaceuticals closed its Series A financing round of $2 M, increasing the total capital raised to over $2.4 M.  The round was led by CONTINUUS’s new strategic partner I.M.A. Industria Macchine Automatiche. I.M.A. is a…
Wednesday, February 12th, 2014

CONTINUUS receives an additional seed investment, taking the company to a total capitalization of $395,000

Thursday, October 17th, 2013

ICM Technology featured in Nature

“Integrated Continuous Manufacturing promises to save time and money” Nature 502, 274 (17 October 2013): http://www.nature.com/nature/journal/v502/n7471/full/502274d.html following our recent peer-reviewed scientific publication this month on Angew. Chem. Int.…
Friday, October 4th, 2013

CONTINUUS participates in Industry Executive Panel in Bay Area event for Manufacturing Day

CONTINUUS Pharmaceuticals’ CEO, Salvatore Mascia, participated on a panel discussion with other industry leaders at the Biomedical Manufacturing and Technology Networking Summit in San Francisco on Oct 4 2013.…
Tuesday, October 1st, 2013

Jonathan Fleming and Tom Van Laar to join CONTINUUS Pharmaceuticals advisory board

CONTINUUS Pharmaceuticals is proud to announce two new members of its advisory board.  Jonathan Fleming is the Managing Partner of Oxford Bioscience Partners, and Tom Van Laar is the Former Head of Global Technical Operation at Novartis Pharmaceuticals. More information…
Friday, May 24th, 2013

Finalist in MassChallenge Accelerator 2013

CONTINUUS Pharmaceuticals is among the 128 Finalists at MassChallenge 2013…
Tuesday, May 14th, 2013

TechConnect 2013 National & Global Innovation Award

The TechConnect Innovation Awards identify the top 20% of submitted technologies as ranked by the TechConnect Corporate & Investment Partner Committee.…
Wednesday, May 1st, 2013

CONTINUUS receives 265K in seed funding

CONTINUUS Pharmaceuticals completed its first seed financing…
Monday, April 15th, 2013

Semifinalist MIT 100K Competition

CONTINUUS was among the 2013 MIT $100K LAUNCH contest semifinalists…
Sunday, March 24th, 2013

ICM Technology was Runner-Up in 2012 Wall Street Journal Manufacturing Technology Competition

Novartis-MIT Center for Continuous Manufacturing places second in Wall Street Journal Competition on October 16, 2012.…
Thursday, March 7th, 2013

Early-Stage Life Sciences Technology Conference 2013

Early-Stage Life Sciences Technology Conference on April 9th, 2013 – oral presentation and poster…
Thursday, March 7th, 2013

University Research and Entrepreneurship Symposium (URES 2013)

CONTINUUS is among the “30 breakthrough technologies in the country developed at key universities” that presented at University Research and Entrepreneurship Symposium (URES 2013) in Cambridge on April 3rd…
Thursday, March 7th, 2013

Life Sciences and Healthcare Venture Summit 2013

CONTINUUS is among the “Top 50 Innovators” presenting at the Life Sciences and Healthcare Venture Summit in NYC on March 20th…